Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology

The effect of infection history is ignored in most animal models of infectious disease. The attachment protein of respiratory syncytial virus (RSV) induces T helper cell type 2–driven pulmonary eosinophilia in mice similar to that seen in the failed infant vaccinations in the 1960s. We show that previous influenza virus infection of mice: (a) protects against weight loss, illness, and lung eosinophilia; (b) attenuates recruitment of inflammatory cells; and (c) reduces cytokine secretion caused by RSV attachment protein without affecting RSV clearance. This protective effect can be transferred via influenza-immune splenocytes to naive mice and is long lived. Previous immunity to lung infection clearly plays an important and underestimated role in subsequent vaccination and infection. The data have important implications for the timing of vaccinations in certain patient groups, and may contribute to variability in disease susceptibility observed in humans.

[1]  C. Heilman.  From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. , 1990, The Journal of infectious diseases.

[2]  J. Altman,et al.  In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. , 1998, Advances in experimental medicine and biology.

[3]  A. Hall,et al.  Measles and atopy in Guinea-Bissau , 1996, The Lancet.

[4]  C. Biron,et al.  Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production. , 1999, Journal of immunology.

[5]  P. Matricardi,et al.  Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis a virus , 1997, BMJ.

[6]  M. Croft,et al.  Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. , 1994, Journal of immunology.

[7]  P. Pileri,et al.  Antigen-independent activation of naive and memory resting T cells by a cytokine combination , 1994, The Journal of experimental medicine.

[8]  P. Sly,et al.  Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. , 1998, Journal of immunology.

[9]  H. Beug,et al.  Thymocyte apoptosis induced by elevated endogenous corticosterone levels , 1994, European journal of immunology.

[10]  P. Schatz.  Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coli , 1993, Bio/Technology.

[11]  R. Welsh,et al.  Minimal Bystander Activation of CD8 T Cells during the Virus-induced Polyclonal T Cell Response , 1997, The Journal of experimental medicine.

[12]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[13]  J. M. Fishaut,et al.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. , 1980, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[14]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[15]  A. O’Garra,et al.  CD8+ T cells control Th2‐driven pathology during pulmonary respiratory syncytial virus infection , 1997, European journal of immunology.

[16]  S. Romagnani.  Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? , 1992, Immunology today.

[17]  H. Pircher,et al.  Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology , 1998, The Journal of experimental medicine.

[18]  D. Kemeny,et al.  Immune regulation: a new role for the CD8+ T cell. , 1994, Immunology today.

[19]  R. Welsh,et al.  Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses , 1994, The Journal of experimental medicine.

[20]  J. Orange,et al.  Effects of IL-12 on the response and susceptibility to experimental viral infections. , 1994, Journal of immunology.

[21]  J. Watson,et al.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells , 1993, The Journal of experimental medicine.

[22]  P. Openshaw,et al.  Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. , 1993, Journal of immunology.

[23]  R. Zinkernagel,et al.  Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model , 1997, The Journal of experimental medicine.

[24]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[25]  R. Welsh,et al.  Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. , 1997, Journal of immunology.

[26]  C. Bangham,et al.  Cytotoxic T-cell response to respiratory syncytial virus in mice , 1985, Journal of virology.

[27]  M. Oldstone,et al.  Viral Infection of Transgenic Mice Expressing a Viral Protein in Oligodendrocytes Leads to Chronic Central Nervous System Autoimmune Disease , 1996, The Journal of experimental medicine.

[28]  S. Varga,et al.  Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations , 1998, The Journal of experimental medicine.

[29]  B. Björkstén,et al.  Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. , 1995, Pediatrics.

[30]  Ayne,et al.  ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .

[31]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[32]  P. Openshaw,et al.  Distinct types of lung disease caused by functional subsets of antiviral T cells , 1994, The Journal of experimental medicine.

[33]  S. Miller,et al.  Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading , 1997, Nature Medicine.

[34]  J. Dalton,et al.  Fasciola hepatica Suppresses a Protective Th1 Response against Bordetella pertussis , 1999, Infection and Immunity.

[35]  A. O’Garra,et al.  Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. , 1996, The Journal of general virology.

[36]  The Inverse Association Between Tuberculin Responses and Atopic Disorder , 1997, Science.

[37]  K. Tanaka,et al.  The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. , 1997, Journal of immunology.

[38]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[39]  G. Rook,et al.  Give us this day our daily germs. , 1998, Biologist.

[40]  K. Tracey,et al.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia , 1989, The Journal of experimental medicine.

[41]  R. Coffman,et al.  A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells , 1996, The Journal of experimental medicine.

[42]  Troy Krahl,et al.  Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry , 1998, Nature Medicine.

[43]  P. Holt,et al.  Development of long-term tolerance versus sensitisation to environmental allergens during the perinatal period. , 1997, Current opinion in immunology.

[44]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[45]  R. Welsh,et al.  Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections , 1996, The Journal of experimental medicine.

[46]  J. Holloway,et al.  Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia , 1998, The Journal of experimental medicine.

[47]  P. Sly,et al.  Development of allergen-specific T-cell memory in atopic and normal children , 1999, The Lancet.

[48]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[49]  T. Braciale,et al.  Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection , 1997, The Journal of experimental medicine.

[50]  L. Anderson,et al.  Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern , 1996, Journal of virology.

[51]  J. Berzofsky,et al.  Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: Association of viral persistence with egg granuloma formation , 1994, European journal of immunology.